Healthcare
The impact of anti-obesity drugs
Could anti-obesity drugs transform healthcare? Jenny Chang, portfolio manager with Goldman Sachs Asset Management, separates the signal from the noise.
Related Tags
Subscribe to Briefings
Our weekly newsletter delivers the latest insights on economic forces shaping markets—from Goldman Sachs leaders, economists, and investors around the world.
You can unsubscribe at any time. For information about how your personal data will be used, visit Privacy Information and Resources.